Further, IDH1 R132Q expression led to activation of several pro-tumor pathways, including those associated with EGFR and PI3K signaling reminiscent of lower grade mutant IDH1 tumors that progress to higher grade. The gene discussed is IDH1; the disease is neoplasm.